| CPX-351对比“7+3”化疗在初诊高危或继发性急性髓系白血病老年患者中的5年随访结果 |
| |
| 引用本文： | 申恒,魏辉,谈家齐. CPX-351对比“7+3”化疗在初诊高危或继发性急性髓系白血病老年患者中的5年随访结果[J]. 循证医学, 2022, 22(2): 84-86. DOI: 10.12019/j.issn.1671-5144.2022.02.003 |
| |
| 作者姓名： | 申恒 魏辉 谈家齐 |
| |
| 作者单位： | 1.中国医学科学院血液病医院、中国医学科学院血液学研究所, 天津 300020; 2.广东省人民医院血液科、广东省医学科学院, 广州 510080 |
| |
| 摘 要： |
|
| 关 键 词： | 急性髓系白血病 CPX-351 老年 |
5-Year Follow-Up Results of CPX-351 Versus 7+3 Chemotherapy in Older Adults With Newly Diagnosed High-Risk or Secondary Acute Myeloid Leukaemia |
| |
| SHEN Heng,WEI Hui,TAN Jia-qi. 5-Year Follow-Up Results of CPX-351 Versus 7+3 Chemotherapy in Older Adults With Newly Diagnosed High-Risk or Secondary Acute Myeloid Leukaemia[J]. The Journal of Evidence-Based Medicine, 2022, 22(2): 84-86. DOI: 10.12019/j.issn.1671-5144.2022.02.003 |
| |
| Authors: | SHEN Heng WEI Hui TAN Jia-qi |
| |
| Affiliation: | Reviewers' address：Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China |
| |
| Abstract: | |
| |
| Keywords: | acute myeloid leukemia CPX-351 orderly |
|
| 点击此处可从《循证医学》浏览原始摘要信息 |
|
点击此处可从《循证医学》下载全文 |
